for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover Medtech Insight
  [0 followers]  Follow
    
   Full-text available via subscription Subscription journal
   ISSN (Print) 1876-8008
   Published by Informa plc Homepage  [16 journals]
  • Abbott's Absorb GT1 Is First FDA-Approved Absorbable Coronary Stent
    • Abstract: Following the near-unanimous advice of its advisory panel, the US FDA approved Abbott Laboratories’ Absorb GT1 everolimus-eluting biodegradable poly(L-lactide) scaffold, making it the first bioresorbable coronary stent commercially available in the US.
      PubDate: Thu, 07 Jul 2016 11:00:01 -040
       
  • China Plan To Exempt More Devices From Trials To Save Time, Costs
    • Abstract: China's Food and Drug Administration invited feedback on a new batch of medical devices that it intends to exempt from having to undergo local clinical trials. The agency's proposal, if adopted, would make it much easier and less costly for companies that want to place these devices on the Chinese market.
      PubDate: Tue, 05 Jul 2016 03:00:09 -040
       
  • Medtronic Takes Next Step As Heart-Failure Service Provider
    • Abstract: The firm signaled its plan three years ago to transform itself into more of a services partner for hospitals than a product supplier. It took the latest step in that direction with the launch of service for heart-failure management, combing data from its cardiac rhythm management devices and its remote-monitoring offerings.
      PubDate: Tue, 05 Jul 2016 03:00:01 -040
       
  • Cenna Biosciences Inc.
    • Abstract: Cenna Biosciences thinks it has come up with a way to target amyloid beta that will succeed where other companies have failed in Alzheimer’s disease. The San Diego-based start-up has developed technology that creates peptide drug candidates that bind the amyloid precursor protein, to prevent amyloid beta buildup in the first place.
      PubDate: Fri, 01 Jul 2016 03:00:01 -040
       
  • BioDirection Inc.
    • Abstract: BioDirection Inc. is poised to launch what it says is the first objective point-of-care test for diagnosing concussion and other traumatic brain injury. Based on proprietary nanotechnology, the company’s Tbit device detects molecular levels of two crucial brain biomarkers that are released into the bloodstream immediately after a brain injury, from just a single drop of blood in less than two minutes.
      PubDate: Thu, 30 Jun 2016 03:00:00 -040
       
  • Medtech Execs On The Move, June 2016
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Tue, 28 Jun 2016 03:00:02 -040
       
  • Diagnostics A Bright Spot In Lackluster US Interventional Cardiology
           Market
    • Abstract: The US Market for interventional cardiology products, which includes diagnostic and therapeutic products, is anticipated to expand from an estimated $3.3 billion in 2015 to roughly $3.6 billion in total product sales by the year 2020. One bright spot in this otherwise lackluster market is the interventional diagnostic products segment, which is projected to grow at CAGR of 4.7% and reach almost $1 billion by 2020, according to a report by Medtech Insight.
      PubDate: Thu, 23 Jun 2016 03:00:01 -040
       
  • Device That Breaches Blood-Brain Barrier Gives Glioblastoma Hope - And
           Alzheimer’s'
    • Abstract: A novel ultrasound technology designed to optimize chemotherapy delivery to the brain gives hope to patients with aggressive brain tumors and could potentially be used to treat Alzheimer's. CarThera's SonoCloud showed promise in preliminary findings from a first in human study, and the technology could hit the market four years from now.
      PubDate: Tue, 21 Jun 2016 03:00:07 -040
       
  • Neuromodulation Update: Mainstay Medical Raises €30m ($34m),
           Bluewind Medical Secures CE Mark
    • Abstract: Mainstay Medical raised an additional €30m ($34m) to fund the German launch and US PMA trial of its recently CE marked ReActiv8 implantable neurostimulation device for chronic low back pain. Bluewind Medical secured CE Mark for tibial neurostimulator for overactive bladder (OAB).
      PubDate: Tue, 21 Jun 2016 03:00:02 -040
       
  • Intuitive Surgical Builds Up Informatics Focus With Partnership
    • Abstract: Under a deal announced June 13, Intuitive and the telehealth firm InTouch Health will collaborate to develop informatics capabilities for Intuitive's da Vinci robotic surgery system, with a particular focus on developing tools to provide surgeons 3D anatomy reconstructions via a cloud network.
      PubDate: Thu, 16 Jun 2016 03:00:01 -040
       
  • Ablation Therapies Emerging As Gentler Approach To Breast Cancer
    • Abstract: Use of ablation technology is emerging as a potentially gentler treatment option for breast cancer, and cryo and thermal ablation in particular are on the verge of regulatory approval that could lead to wider use. A growing number of physicians are already using cryotherapy for breast cancer, but without FDA clearance, reimbursement can be a difficult issue.
      PubDate: Wed, 15 Jun 2016 18:50:01 -040
       
  • Top Medtech Markets Lag Behind In Connected Health Readiness
    • Abstract: Some of the world's biggest Medtech markets lag behind emerging markets in connected health readiness according to the Future Health Index study, a new research report commissioned by Philips.
      PubDate: Tue, 14 Jun 2016 03:00:01 -040
       
  • Zimmer Biomet Buys LDR To Boost Spine Revenue Growth
    • Abstract: The world's second-largest orthopedic device firm, Zimmer Biomet, is making its biggest move since Zimmer and Biomet merged in 2015 with a $1 billion acquisition of spine-device specialists LDR.
      PubDate: Thu, 09 Jun 2016 03:00:06 -040
       
  • Cardialen Inc.
    • Abstract: Cardialen's hybrid implantable pacemaker/defibrillator for atrial fibrillation monitors the heart beat by beat. At the first sign of arrhythmia it delivers a low-level electrical pulse to convert the patient's irregularity back to a normal heart rhythm.
      PubDate: Thu, 09 Jun 2016 03:00:02 -040
       
  • Blood Filter Start-Up ExThera Gets Fresenius Backing
    • Abstract: New investor Fresenius Medical Care Ventures GmbH is leading a Series B financing round in ExThera Medical to help fund clinical trials in Germany and the US of the latter’s Seraph Microbind affinity blood filter.
      PubDate: Tue, 07 Jun 2016 03:00:08 -040
       
  • Medical Device Deals Update, June 2016
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced April-May 2016.
      PubDate: Tue, 07 Jun 2016 03:00:01 -040
       
  • Advanced Cooling Therapy Inc.
    • Abstract: Advanced Cooling Therapy Inc. has developed a novel device that control's a patient’s entire body temperature by either heating or cooling blood surrounding the esophagus.
      PubDate: Thu, 02 Jun 2016 03:00:02 -040
       
  • Robotic-Assisted Surgery: Taking MIS By Storm
    • Abstract: Robotically assisted surgical devices are one of the hottest and fastest growing segments in the market for minimally invasive surgery (MIS) products, with a global market opportunity projected to reach more than $10 billion by 2021. A growing number of competitors hope to capture share and further expand the market by targeting key procedures and geographies with next generation robotic surgery systems and robotic-like technologies designed to improve outcomes and enable more complex procedures to be performed via an MIS approach.
      PubDate: Thu, 26 May 2016 03:00:06 -040
       
  • MiNDERA Corp.
    • Abstract: MiNDERA Corp. is developing an alternative to punch biopsies for diagnosing skin cancer: its microneedle device extracts biomarkers from the skin in a procedure that the start-up says is highly accurate and cost-effective for office-based diagnostic applications in dermatology.
      PubDate: Thu, 26 May 2016 03:00:01 -040
       
  • Sinclair Pharma's Non-Surgical Facelift Gains Access To US Market Via
           Thermigen Deal
    • Abstract: Sinclair Pharma has gained access to the world’s largest aesthetics market by enlisting Thermigen as the exclusive US distributor of Silhouette InstaLift, a non-surgical alternative to facelifts.
      PubDate: Tue, 24 May 2016 03:00:18 -040
       
  • 4Tech Inc.
    • Abstract: 4Tech Inc. has developed a dedicated transcatheter system to treat tricuspid regurgitation. ItsTriCinch applies tension to an anchor placed on the annulus of the tricuspid valve, thus reducing the size of the native annulus and limiting the amount of blood that can backflow through the valve.
      PubDate: Tue, 24 May 2016 03:00:02 -040
       
  • Siemens Makes First Molecular Dx Buy In 9 Years
    • Abstract: Siemens Healthineers, the new brand name for Siemens Healthcare, has acquired NEO New Oncology, a privately held German company developing molecular profiling assays based on next-generation sequencing of circulating tumor DNA. The deal marks Siemens’ first molecular diagnostic acquisition since it bought US firm Dade Behring for $7bn in 2007.
      PubDate: Thu, 19 May 2016 03:00:06 -040
       
  • Medtronic Bets On Future Mazor Robotics Spine Surgery Systems
    • Abstract: Medtronic is putting its sales and marketing power behind Israel-based Mazor Robotics with new commercial agreement and investment deals, both announced May 18.
      PubDate: Thu, 19 May 2016 03:00:02 -040
       
  • TEVAR 2016: Companies Push New Frontiers In Thoracic Aortic Interventions
    • Abstract: Although thoracic endovascular aortic repair (TEVAR) is now routine for lesions like dissection of the descending aorta, the Big Three aortic endovascular companies are developing devices for the more technically challenging proximal and distal portions of the thoracic aorta while physicians refine TEVAR in the descending aorta. Insiders say endovascular techniques are overcoming limitations and physicians will soon be able to treat the entire aorta, from the aortic valve to the bifurcation.
      PubDate: Tue, 17 May 2016 03:00:00 -040
       
  • EFFORTLESS Trial Of Boston Scientific’s S-ICD Headlines HRS 2016
    • Abstract: Results from EFFORTLESS, the largest post-market registry of Boston Scientific’s S-ICD (subcutaneous ICD), support the technology as an option for a broad population of ICD candidates. Researchers presented data from the registry on May 6 at the Heart Rhythm Society Scientific Sessions in San Francisco.
      PubDate: Thu, 12 May 2016 03:00:04 -040
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 54.224.197.217
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2016